Literature DB >> 12895387

Simian virus 40 and its association with human lymphomas.

Regis A Vilchez1, Janet S Butel.   

Abstract

Simian virus 40 (SV40) is a potent DNA tumor virus that is known to induce cancer in laboratory animals. The neoplasias induced by SV40 in animal models are brain cancers, mesothelioma, bone cancers, and systemic lymphomas. SV40 oncogenesis is mediated primarily by the viral large tumor antigen, which inactivates the tumor suppressor proteins p53 and pRb family members. Evidence indicates that SV40 is an emergent human pathogen and that a significant excess risk of SV40 is associated with primary human brain cancers, malignant mesothelioma, bone cancers, and non-Hodgkin's lymphoma. Therefore, the major types of tumors induced by SV40 in laboratory animals are the same as those human malignancies found to contain SV40 markers. Experimental and clinical data indicate that SV40 may be functionally important in the development of some of those malignancies. Recently, the Institute of Medicine of the National Academies concluded that SV40 infections could lead to cancer in humans under natural conditions (based on moderate strength biologic evidence). This review examines the data implicating SV40 in the pathogenesis of human lymphomas and discusses future directions to define the causative role for SV40 in these malignancies.

Entities:  

Mesh:

Year:  2003        PMID: 12895387     DOI: 10.1007/s11912-003-0021-y

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  56 in total

Review 1.  Transforming functions of Simian Virus 40.

Authors:  M T Sáenz-Robles; C S Sullivan; J M Pipas
Journal:  Oncogene       Date:  2001-11-26       Impact factor: 9.867

2.  AIDS-related systemic non-Hodgkin's lymphoma at a large community program.

Authors:  Regis A Vilchez; Claudia A Kozinetz; Jeffrey L Jorgensen; Michael H Kroll; Janet S Butel
Journal:  AIDS Res Hum Retroviruses       Date:  2002-03-01       Impact factor: 2.205

3.  Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40.

Authors:  Eric A Engels; Hormuzd A Katki; Nete M Nielsen; Jeanette F Winther; Henrik Hjalgrim; Flemming Gjerris; Philip S Rosenberg; Morten Frisch
Journal:  J Natl Cancer Inst       Date:  2003-04-02       Impact factor: 13.506

4.  Enumeration of the simian virus 40 early region elements necessary for human cell transformation.

Authors:  William C Hahn; Scott K Dessain; Mary W Brooks; Jessie E King; Brian Elenbaas; David M Sabatini; James A DeCaprio; Robert A Weinberg
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

5.  Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas.

Authors:  S Weggen; T A Bayer; A von Deimling; G Reifenberger; D von Schweinitz; O D Wiestler; T Pietsch
Journal:  Brain Pathol       Date:  2000-01       Impact factor: 6.508

Review 6.  SV40 and human tumours: myth, association or causality?

Authors:  Adi F Gazdar; Janet S Butel; Michele Carbone
Journal:  Nat Rev Cancer       Date:  2002-12       Impact factor: 60.716

7.  SV40 infection induces telomerase activity in human mesothelial cells.

Authors:  Rudy Foddis; Assunta De Rienzo; Dominique Broccoli; Maurizio Bocchetta; Elizabeth Stekala; Paola Rizzo; Alessandra Tosolini; Jennifer V Grobelny; Suresh C Jhanwar; Harvey I Pass; Joseph R Testa; Michele Carbone
Journal:  Oncogene       Date:  2002-02-21       Impact factor: 9.867

8.  BK virus and SV40 co-infection in polyomavirus nephropathy.

Authors:  Rui-Mei Li; Roslyn B Mannon; David Kleiner; Maria Tsokos; Michelle Bynum; Allen D Kirk; Jeffrey B Kopp
Journal:  Transplantation       Date:  2002-12-15       Impact factor: 4.939

Review 9.  Cell and molecular biology of simian virus 40: implications for human infections and disease.

Authors:  J S Butel; J A Lednicky
Journal:  J Natl Cancer Inst       Date:  1999-01-20       Impact factor: 13.506

10.  Molecular identification of SV40 infection in human subjects and possible association with kidney disease.

Authors:  Rui-Mei Li; Mary H Branton; Somsak Tanawattanacharoen; Ronald A Falk; J Charles Jennette; Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

View more
  4 in total

1.  The detection of CMV pp65 and IE1 in glioblastoma multiforme.

Authors:  Kenneth G Lucas; Lei Bao; Richard Bruggeman; Kimberly Dunham; Charles Specht
Journal:  J Neurooncol       Date:  2010-09-05       Impact factor: 4.130

2.  A safety-modified SV40 Tag developed for human cancer immunotherapy.

Authors:  Stephanie S Tseng-Rogenski; Mohamed S Arredouani; June F Escara-Wilke; Yilin C Neeley; Michael J Imperiale; Martin G Sanda
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

3.  Fanconi anemia patients are more susceptible to infection with tumor virus SV40.

Authors:  Manola Comar; Daniela De Rocco; Enrico Cappelli; Nunzia Zanotta; Roberta Bottega; Johanna Svahn; Piero Farruggia; Aldo Misuraca; Fabio Corsolini; Carlo Dufour; Anna Savoia
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

4.  Simian Virus 40 Large T Antigen as a Model to Test the Efficacy of Flouroquinolones against Viral Helicases.

Authors:  Sammer Siddiqui; Muhammad F Anwar; Sadaf Naeem; Syed Hani Abidi; Shamshad Zarina; Syed Ali
Journal:  Bioinformation       Date:  2018-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.